News headlines

News headlines on clinical trials, public health, human experimentation, ethics in South Asia

1st April 2013

Indian Supreme Court refuses Novartis's patent on Glivec. 'Access to the large markets at risk - must find creative strategies to include the poor'.


3rd May 2012

Cipla - the Indian generics manufacturer - has overtaken Bayer's monopoly of cancer drug Nexavar and will sell it for 75% less. Reported by Reuters:


20th March 2012

Stop TB Partnership announces global vaccines strategy:


14th March 2012 

Drug major AstraZeneca is now looking at India and China to pursue  much of their research and development initiatives. http://pharmabiz.com/NewsDetails.aspx?aid=67988&sid=1


12th March 2012 

In a landmark case, the Indian Patent Office has issued the first-ever compulsory licence in India to a generic drug manufacturer.
More: http://www.msfaccess.org/about-us/media-room/press-releases/india-issues-first-compulsory-licence   and
http://www.nytimes.com/2012/03/13/business/global/india-overrules-bayer-allowing-generic-drug.html?_r=1&src=busln


4th March 2012 

The US TV network NBC has made an investigative documentary on drug trials by MNCs, which can be viewed at: http://on.msnbc.com/yggq0V